]>
IRCT20190305042935N2 IRCT 2020-03-14 Shahre-kord University of Medical Sciences Effect of alkaline water in treatment of gastroesophageal reflux Evaluation of the therapeutic effect of alkaline water in patients with gastroesophageal reflux disease 2019-05-31 anticipated 72 Complete https://irct.ir/trial/45964 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Convenience sampling will be done. To this end, 72 cards of the same size and shape will be labelled A and B one by one, and then patients will randomly pick one card in order of their enrollment in the study and will be assigned to either group according to the label of the card they picked, Blinding description: In this study considering the use of similar bottles in all two groups, participants, researcher and the assessor, are not aware of the contents of the bottles and the groups will be checked with the names A and B. 3 Gastroesophageal reflux disease. Intervention 1: Intervention group: This group will receive at least 1.3 liters of alkaline water (bottle A) daily regardless of specific consumption pattern and based on routine consumption. For the preparation of alkaline water, ordinary mineral water is contacted with the catalyst and collected in a bottle and provided to the patient. Intervention 2: Control group: This group will receive 1.3 liters of ordinary mineral water (bottle B) daily regardless of specific consumption pattern and based on routine consumption. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information
public Doctor Ghorbanali Rahimian
Faculty of medicine, Shahrekord University of Medical Science, Rahmatiyeh
Shahrekord Iran (Islamic Republic of) ۸۸۱۵۷۱۳۴۷۱ +98 38 3333 5653 ghorbanali.rahimian@gmail.com Shahre-kord University of Medical Sciences scientific Doctor Ghorbanali Rahimian
Faculty of medicine, Shahrekord University of Medical Science, Rahmatiyeh
Shahrekord Iran (Islamic Republic of) ۸۸۱۵۷۱۳۴۷۱ +98 38 3333 5653 ghorbanali.rahimian@gmail.com Shahre-kord University of Medical Sciences Iran (Islamic Republic of) Iran (Islamic Republic of) Symptoms of gastroesophageal reflux disease at least 2 times a week for at least 3 months Age between 18 to 40 years 18 years 40 years Both Any pathological problem associated with gastroesophageal reflux disease including Barrett's esophagus and malignancy Having warning signs such as painful and difficulty swallowing, nausea, vomiting and fever K21 Gastro-esophageal reflux disease Treatment - Drugs Placebo Intervention group: This group will receive at least 1.3 liters of alkaline water (bottle A) daily regardless of specific consumption pattern and based on routine consumption. For the preparation of alkaline water, ordinary mineral water is contacted with the catalyst and collected in a bottle and provided to the patient. Control group: This group will receive 1.3 liters of ordinary mineral water (bottle B) daily regardless of specific consumption pattern and based on routine consumption. Mean scores of gastrointestinal symptoms in GERD questionnaire. Timepoint: Before the intervention and six-week after intervention. Method of measurement: Gastroesophageal Reflux Disease (GERD) questionnaire. Shahre-kord University of Medical Sciences Approved 2018-10-07 Ethics committee of Shahrekord University of Medical Sciences Research Deputy, Shahrekord University of Medical Sciences, Kashani Street, Shahrekord Shahrekord Chahar-Mahal-va-Bakhtiari Iran (Islamic Republic of)